Pathogenesis of Sodium Retention in Cirrhosis: The Arterial Vasodilation Hypothesis of Ascites Formation

Ascites and Renal Dysfunction in Liver Disease: Pathogenesis, Diagnosis, and Treatment: Second Edition

Volumn , Issue , 2007, Pages 199-214

  Fernández Llama, Patricia ^a   Ginès, Pere ^b   Schrier, Robert W ^c  

^a FUNDACIÓ PUIGVERT   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Ascites; Cirrhosis; Hepatorenal syndrome; Pathogenesis; Sodium retention

Indexed keywords

EID: 84889419131     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470987476.ch16     Document Type: Chapter

References (118)

1. Ginès P, Rodés J. Clinical disorders of renal function in cirrhosis with ascites. In: Arroyo V, Ginès P, Rodés J, Schrier RW, eds. Ascites and Renal Dysfunction in Liver Disease. Oxford: Blackwell, 1999; 36-62.
2. Ginès P, Cardenas A, Schrier RW. Liver disease and the kidney. In: Schrier RW, ed. Diseases of the Kidney and Urinary Tract. Philadelphia: Lippincott, Williams & Wilkins, 2001; 2167-203.
3. Schrier RW, Niederbeger M, Weigert A, Ginès P. Peripheral arterial vasodilation: determinant of functional spectrum of cirrhosis. Semin Liver Dis 1994; 14:14-22.
4. Ginès P, Berl T, Bernardi M et al. Hyponatremia in cirrhosis: from pathogenesis to treatment. Hepatology 1998; 28:851-64.
5. Cardenas A, Ginès P. Pathogenesis and treatment of fluid and electrolyte imbalance in cirrhosis. Semin Nephrol 2001; 21:308-16.
6. Arroyo V, Ginès P, Gerbes AL et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 1996; 23:164-76.
7. Ginès P, Martin PY, Niederberger M. Prognostic significance of renal dysfunction in cirrhosis. Kidney Int 1997; 52 (Suppl. 61):S77-S82.
8. González-Campoy JM, Knox FG. Integrated responses of the kidney to alterations in extracellular fluid volume. In: Seldin DW, Giebisch G, eds. The Kidney: Physiology and Pathophysiology. New York: Raven Press, 1992; 2041-98.
9. Ginès P, Humphreys M, Schrier RW. Edema. In: Massry SG, Glassock RJ, eds. Textbook of Nephrology. Baltimore: Williams & Wilkins, 1995; 582-9.
10. Abboud F, Thames M. Interaction of cardiovascular reflexes in circulatory control. In: Shepherd JT, Abboud FM, Geiger SR, eds. Handbook of Physiology. The Cardiovascular System. Baltimore: Waverly Press, 1983; 675-753.
11. Shepherd JT. Cardiac mechanoreceptors. In: Fozzard HA, Haber A, Jennings RB et al., eds. The Heart and Cardiovascular System. New York: Raven Press, 1992; 1481-504.
12. Farnsworth EB, Krakusin JS. Electrolyte partition in patients with edema of various origins. J Lab Clin Med 1948; 33:1545-54.
13. Eisenmenger WJ, Blondheim SH, Bongiovanni AM, Kunkel HG. Electrolyte studies on patients with cirrhosis of the liver. J Clin Invest 1950; 29:1491-9.
14. Arroyo V, Rodés J. A rational approach to the treatment of ascites. Postgrad Med J 1975; 51:558-62.
15. Levy M. Sodium retention and ascites formation in dogs with experimental portal cirrhosis. Am J Physiol 1977; 233: F572-F585.
16. Levy M, Allotey JB. Temporal relationships between urinary salt retention and altered systemic hemodynamics in dogs with experimental cirrhosis. J Lab Clin Med 1978; 92:560-9.
17. López-Novoa JM, Rengel MA, Hernando L. Dynamics of ascites formation in rats with experimental cirrhosis. Am J Physiol 1980; 238:F353-F357.
18. Jiménez W, Martínez-Pardo A, Arroyo V et al. Temporal relationship between hyperaldosteronism, sodium retention and ascites formation in rats with experimental cirrhosis. Hepatology 1985; 5:245-50.
19. Denison EK, Lieberman FL, Reynolds TB. 9-Fluorohydrocortisone induced ascites in alcoholic disease. Gastroenterology 1971; 61:497-503.
20. La Villa G, Salmerón JM, Arroyo V et al. Mineralocorticoid escape in patients with compensated cirrhosis and portal hypertension. Gastroenterology 1992; 102:2114-19.
21. Epstein M, Lifschitz M, Ramachandran M, Rappaport K. Characterization of renal PGE responsiveness in decompensated cirrhosis: implications for renal sodium handling. Clin Sci 1982; 63:555-63.
22. Daskalopoulos G, Kronborg I, Katkov W et al. Sulindac and indomethacin suppress the diuretic action of furosemide in patients with cirrhosis and ascites: evidence that sulindac affects renal prostaglandins. Am J Kidney Dis 1985; 6:217-21.
23. Ginès P, Fernández-Esparrach G, Arroyo V, Rodés J. Pathogenesis of ascites in cirrhosis. Semin Liver Dis 1997; 17:175-89.
24. Blendis LM, Greig PD, Langer B et al. The renal and hemodynamic effects of the peritoneovenous shunt for intractable hepatic ascites. Gastroenterology 1979; 77:250-7.
25. Ginès P, Arroyo V, Vargas V et al. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. N Engl J Med 1991; 325:829-35.
26. Ginès P, Uriz J, Calahorra B et al. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology 2002; 12:1839-47.
27. Bernardi M, Laffi G, Salvagnini M et al. Efficacy and safety of the stepped care medical treatment of ascites in liver cirrhosis: a randomized controlled clinical trial comparing two diets with different sodium content. Liver 1993; 13:156-62.
28. Papper S, Rosenbaum JD. Abnormalities in the excretion of water and sodium in "compensated" cirrhosis of the liver. J Lab Clin Med 1952; 40:523-30.
29. Bosch J, Arroyo V, Rodés J. Hepatic and systemic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis. In: Epstein M, ed. The Kidney in Liver Disease. New York: Elsevier Biomedical, 1983; 286-308.
30. Lieberman FL, Reynolds TB. Plasma volume in cirrhosis of the liver: its relation to portal hypertension, ascites, and renal failure. J Clin Invest 1967; 46:1297-307.
31. Bernardi M, Trevisani F, Santini C et al. Aldosterone related blood volume expansion in cirrhosis before and after the early phase of ascites formation. Gut 1983; 24:761-6.
32. Caregaro L, Lauro S, Angeli P et al. Renal water and sodium handling in compensated liver cirrhosis: mechanism of the impaired natriuresis after saline loading. Eur J Clin Invest 1985; 15:360-5.
33. Wood LJ, Massie D, McLean AJ, Dudley FJ. Renal sodium retention in cirrhosis: tubular site and relation to hepatic dysfunction. Hepatology 1988; 8:831-6.
34. Bernardi M, Di Marco C, Trevisani F et al. Renal sodium retention during upright posture in preascitic cirrhosis. Gastroenterology 1993; 105:188-93.
35. Trevisani F, Bernardi M, Gasbarrini A et al. Bed-rest-induced hypernatriuresis in cirrhotic patients without ascites: does it contribute to maintain "compensation"? J Hepatol 1992; 16:190-6.
36. Bernardi M, Di Marco C, Trevisani F et al. The hemodynamic status of preascitic cirrhosis: an evaluation under steadystate conditions and after postural change. Hepatology 1992; 16:341-6.
37. Bernardi M, Trevisani F, Gasbarrini A, Gasbarrini G. Hepatorenal disorders: role of the renin-angiotensin-aldosterone system. Semin Liver Dis 1994; 14:23-34.
38. Wong F, Massie D, Hsu P, Dudley F. Renal response to a saline load in well-compensated alcoholic cirrhosis. Hepatology 1994; 20:873-81.
39. Simon MA, Diez J, Prieto J. Abnormal sympathetic and renal response to sodium restriction in compensated cirrhosis. Gastroenterology 1991; 101:1354-60.
40. Trevisani F, Colantoni A, Sica G et al. High plasma levels of atrial natriuretic peptide in preascitic cirrhosis: indirect evidence of reduced natriuretic effectiveness of the peptide. Hepatology 1995; 22:132-7.
41. Wong F, Liu P, Allidina Y, Blendis LM. Pattern of sodium handling and its consequences in patients with preascitic cirrhosis. Gastroenterology 1995; 108:1820-7.
42. Naccarato R, Messa P, D'Angelo A et al. Renal handling of sodium and water in early chronic liver disease. Evidence for a reduced natriuretic activity of the cirrhotic urinary extracts in rats. Gastroenterology 1981; 81:205-10.
43. Warner LC, Campbell PJ, Morali G et al. The response of atrial natriuretic factor (ANF) and sodium excretion to dietary sodium challenges in patients with chronic liver disease. Hepatology 1990; 12:460-6.
44. Albillos A, Lledo JL, Rossi I et al. Continuous Prazosin administration in cirrhotic patients: effects on portal hemodynamics and on liver and renal function. Gastroenterology 1995;109:1257-65.
45. Bañares R, Moitinho E, Matilla A et al. Randomized comparison of long term carvedilol and propranolol adminstration in the treatment of portal hypertension in cirrhosis. Hepatology 2002; 36: 1367-73.
46. Schnermann J. NaCl transport deficiencies-hemodynamics to the rescue. Pflugers Arch Eur J Physiol 2000; 439:682-90.
47. Greger R. Physiology of renal sodium transport. Am J Med Sci 2000; 319:51-62.
48. Kim GH, Masilamani S, Turner R, Mitchell C, Wade JB, Knepper MA. The thiazide-sensitive Na-Cl cotransporter is an aldosterone-induced protein. Proc Natl Acad Sci USA 1998; 95:14552-7.
49. Masilamani S, Kim GH, Mitchell C, Wade JB, Knepper MA. Aldosterone-mediated regulation of ENaC α, β, and α subunit proteins in rat kidney. J Clin Invest 1999; 104: R19-R23.
50. Epstein M. Renal sodium handling in liver disease. In: Epstein M, ed. The Kidney in Liver Disease. Philadelphia: Hanley & Belfus, 1996; 1-31.
51. Lopez-Novoa JM, Rengel MA. A micropuncture study of salt and water retention in chronic experimental cirrhosis. Am J Physiol 1977; 232:F315-F318.
52. Bank N, Aynedjian HS. A micropuncture study of renal salt and water retention in chronic bile duct obstruction. J Clin Invest 1975; 55:994-1002.
53. Wilkinson SP, Smith IK, Clarke M et al. Intrarenal distribution of plasma flow in cirrhosis as measured by transit renography: relationship with plasma renin activity, and sodium and water excretion. Clin Sci Mol Med 1977; 52:469-75.
54. Chiandussi L, Bartoli E, Arras S. Reabsorption of sodium in the proximal renal tubule in cirrhosis of the liver. Gut 1978; 19:497-503.
55. Thomsen K. Lithium clearance: a new method for determining proximal and distal tubular reabsorption of sodium and water. Nephron 1984; 37:217-23.
56. Angeli P, Gatta A, Caregaro L et al. Tubular site of renal sodium retention in ascitic liver cirrhosis evaluated by lithium clearance. Eur J Clin Invest 1990; 20:111-17.
57. Diez J, Simon MA, Anton F, Indart FJ, Prieto J. Tubular sodium handling in cirrhotic patients with ascites is analysed by renal lithium clearance method. Eur J Clin Invest 1990; 20:266-71.
58. Sansoe G, Ferrari A, Baraldi E, Castellana CN, De Santis MC, Manenti F. Renal distal tubular handling of sodium in central fluid volume homoeostasis in preascitic cirrhosis. Gut 1999; 45:750-5.
59. Anastasio P, Frangiosa A, Papalia T et al. Renal tubular function by lithium clearance in liver cirrhosis. Semin Nephrol 2001; 21:323-6.
60. Koomans HA, Boer WH, Dorhout Mees EJ. Evaluation of lithium clearance as a marker of proximal tubule sodium handling. Kidney Int 1989; 36:2-12.
61. Shalmi M, Petersen JS, Thomsen K, Christensen S. Distal lithium reabsorption in the sodium-restricted rat is not dependent on the urinary sodium to lithium concentration ratio. Clin Sci (Lond) 1990; 79:109-12.
62. Boer WH, Koomans HA, Dorhout Mees EJ. Lithium clearance in healthy humans suggesting lithium reabsorption beyond the proximal tubules. Kidney Int 1990; 28:S39-S44.
63. Rector WG Jr. "Diuretic-resistant" ascites. Observations on pathogenesis. Arch Intern Med 1986; 146:1597-600.
64. Bernardi M, Laffi G, Salvagnini M et al. Efficacy and safety of the stepped care medical treatment of ascites in liver cirrhosis: a randomized controlled clinical trial comparing two diets with different sodium content. Liver 1993; 13:156-62.
65. Eggert RC. Spironolactone diuresis in patients with cirrhosis and ascites. Br Med J 1970; 4:401-3.
66. Perez-Ayuso RM, Arroyo V, Planas R et al. Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system. Gastroenterology 1983; 84:961-8.
67. Knepper MA, Masilamani S. Targeted proteomics in the kidney using ensembles of antibodies. Acta Physiolog Scand 2001; 173:11-21.
68. Fernandez-Llama P, Andrews P, Ecelbarger CA, Nielsen S, Knepper MA. Concentrating defect in experimental nephrotic syndrome: altered expression of aquaporins and thick ascending limb Na++ transporters. Kidney Int 1998; 54:170-9.
69. Yun CH, Gurubhagavatula S, Levine SA et al. Glucocorticoid stimulation of ileal Na+ absorptive cell brush border Na+/H+ exchange and association with an increase in message for NHE-3, an epithelial Na+/H+ exchanger isoform. J Biol Chem 1993; 268:206-11.
70. DiGiovanni SR, Nielsen S, Christensen EI, Knepper MA. Regulation of collecting duct water channel expression by vasopressin in Brattleboro rat. Proc Natl Acad Sci USA 1994; 91:8984-8.
71. Ecelbarger CA, Knepper MA, Verbalis JG. Increased abundance of distal sodium transporters in rat kidney during vasopressin escape. J Am Soc Nephrol 2001; 12:207-17.
72. Rubera I, Rossier BC, Hummler E. Inactivation of sodiumtransporting proteins in the kidney. Pflugers Arch 2003; 445:463-9.
73. Fernandez-Llama P, Ageloff S, Fernandez-Varo G et al. Sodium retention in cirrhotic rats is associated with increased renal abundance of sodium transporter proteins. Kidney Int 2005; 67:622-30.
74. Jonassen TE, Marcussen N, Haugan K et al. Functional and structural changes in the thick ascending limb of Henle's loop in rats with liver cirrhosis. Am J Physiol 1997; 273: R568-R577.
75. Jonassen TE, Sorensen AM, Petersen JS, Andreasen F, Christensen S. Increased natriuretic efficiency of furosemide in rats with carbon tetrachloride-induced cirrhosis. Hepatology 2000; 31:1224-30.
76. Fernandez-Llama P, Jimenez W, Bosch-Marce M, Arroyo V, Nielsen S, Knepper MA. Dysregulation of renal aquaporins and Na-Cl cotransporter in CCl4-induced cirrhosis. Kidney Int 2000; 58:216-28.
77. Johnston RF, Loo RV. Hepatic hydrothorax. Studies to determine the source of the fluid and report of thirteen cases. Ann Intern Med 1964; 611:385-401.
78. Lieberman FL, Hidemura R, Peters RL, Reynolds TB. Pathogenesis and treatment of hydrothorax complicating cirrhosis with ascites. Ann Intern Med 1966; 64:341-51.
79. Strauss RM, Boyer TD. Hepatic hydrothorax. Semin Liver Dis 1997; 17:227-33.
80. Singer JA, Kaplan MM, Katz RL. Cirrhotic pleural effusion in the absence of ascites. Gastroenterology 1977; 73:575-7.
81. Flaum MA. Spontaneous bacterial empyema in cirrhosis. Gastroenterology 1976; 70:416-17.
82. Xiol X, Castellví JM, Guardiola J et al. Spontaneous bacterial empyema of cirrhotic patients: a prospective study. Hepatology 1996; 23:719-23.
83. Shah A, Variyam E. Pericardial effusion and left ventricular dysfunction associated with ascites secondary to hepatic cirrhosis. Arch Intern Med 1988; 148:585-8.
84. Bhasin DK, Grover A, Singh M et al. Pericardial effusion in alcoholic cirrhosis. Arch Intern Med 1991; 151:816.
85. Arroyo V, Bosch J, Gaya J et al. Plasma renin activity and urinary sodium excretion as prognostic indicators in nonazotemic cirrhosis with ascites. Ann Intern Med 1981; 94:198-201.
86. Genoud E, Gonvers JJ, Schaller MD et al. Valeur pronostique du système rénine-angiotensine dans la réponse à la restriction sodée et le pronostic de l'ascite cirrhotique d'origine alcoolique. Schweiz Med Wochenschr 1986; 116:463-9.
87. Llach J, Ginès P, Arroyo V et al. Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology 1988; 94:482-7.
88. Palmer BF, Alpern RJ, Seldin DW. Pathophysiology of edema formation. In: Seldin DW, Giebisch G, eds. The Kidney. Physiology and Pathophysiology, 2nd edn. New York: Raven, 1992; 2099-142.
89. González-Campoy JM, Knox FG. Integrated responses of the kidney to alterations in extracellular fluid volume. In: Seldin DW, Giebisch G, eds. The Kidney. Physiology and Pathophysiology, 2nd edn. New York: Raven, 1992; 2041-98.
90. Schrier RW. Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis and pregnancy (1). N Engl J Med 1988; 319:1065-72.
91. Schrier RW. Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis and pregnancy (2). N Engl J Med 1988; 319:1127-34.
92. Ginès P, Humphreys M, Schrier RW. Edema. In: Massry SG, Glassock RJ, eds. Textbook of Nephrology, 3rd edn. Baltimore: Williams & Wilkins, 1995; 582-9.
93. Persson PB. Modulation of cardiovascular control mechanisms and their interaction. Physiol Rev 1996; 76:193-244.
94. Abassi ZA, Winaver J, Skorecki KL. Control of extracellular fluid volume and the pathophysiology of edema formation. In: Brenner BM, ed. The Kidney, 7th edn. Philadelphia: Saunders, 2004; 777-855.
95. Epstein FH, Post RS, McDowell M. The effect of an arteriovenous fistula on renal hemodynamics and electrolyte excretion. J Clin Invest 1953; 32:233-41.
96. Epstein FH, Shadle OW, Ferguson TB, McDowell ME. Cardiac output and intracardiac pressure in patients with arteriovenous fistulas. J Clin Invest 1953; 32:543-7.
97. Schrier RW. Body fluid volume regulation in health and disease: a unifying hypothesis. Ann Intern Med 1990; 113:155-9.
98. Abraham WT, Schrier RW. Body fluid regulation in health and disease. In: Schrier RW, Abboud FM, Baxter JD, Fauci AS, eds. Advances in Internal Medicine, vol. 39. Chicago: Mosby Yearbook, 1994.
99. Lieberman FL, Ito S, Reynolds TB. Effective plasma volume in cirrhosis with ascites. Evidence that a decreased value does not account for renal sodium retention, a spontaneous reduction in glomerular filtration rate (GFR), and a fall in GFR during drug-induced diuresis. J Clin Invest 1969; 48:975-81.
100. Lieberman FL, Denison EK, Reynolds TB. The relationship of plasma volume, portal hypertension, ascites, and renal sodium retention in cirrhosis: the overflow theory of ascites formation. Ann NY Acad Sci 1970; 170:202-12.
101. Unikowsky B, Wexler MJ, Levy M. Dogs with experimental cirrhosis of the liver but without intrahepatic hypertension do not retain sodium or form ascites. J Clin Invest 1983; 72:1594-604.
102. Kostreva DR, Castaner A, Kampine JP. Reflex effects of hepatic baroreceptors on renal and cardiac sympathetic nervous activity. Am J Physiol 1980; 238:R390-R394.
103. Levy M, Wexler MJ. Hepatic denervation alters first-phase urinary sodium excretion in dogs with cirrhosis. Am J Physiol 1987; 253:F664-F671.
104. Levy M, Wexler MJ. Sodium excretion in dogs with low grade caval constriction: role of hepatic nerves. Am J Physiol 1987; 253:F672-F678.
105. Wood LJ, Massie D, McLean AJ, Dudley FJ. Renal sodium retention in cirrhosis: tubular site and relation to hepatic dysfunction. Hepatology 1988; 8:831-6.
106. Wensing G, Sabra R, Branch RA. The onset of sodium retention in experimental cirrhosis in rats is related to a critical threshold of liver function. Hepatology 1990; 11:779-86.
107. Rector WG Jr, Lewis F, Robertson AD, Everson GT. Renal sodium retention complicating alcoholic liver disease: relation to portosystemic shunting and liver function. Hepatology 1990; 12:455-9.
108. Ahloulay M, Dechaux M, Hassler C et al. Cyclic AMP is a hepatorenal link influencing natriuresis and contributing to glucagon-induced hyperfiltration in rats. J Clin Invest 1996; 98:2251-8.
109. Levy M. The genesis of urinary sodium retention in preascitic cirrhosis: the overflow theory. Gastroenterol Int 1992; 5:186-91.
110. Levy M. Pathogenesis of sodium retention in early cirrhosis of the liver: evidence for vascular overfilling. Semin Liver Dis 1994; 14:4-13.
111. Witte MH, Witte CL, Dumont AE. Progress in liver disease: physiological factors involved in the causation of cirrhotic ascites. Gastroenterology 1971; 61:742-50.
112. Witte CL, Witte MH, Dumont AE. Lymph imbalance in the genesis and perpetuation of the ascites syndrome in hepatic cirrhosis. Gastroenterology 1980; 78:1059-68.
113. Braunwald E, Colucci WS, Grossman W. Clinical aspects of heart failure; high-output heart failure; pulmonary edema. In: Braunwald E, ed. Heart Disease. A Textbook of Cardiovascular Medicine. Philadelphia: WB Saunders, 1997; 445-70.
114. Groszmann RJ. Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences. Hepatology 1994; 20:1359-63.
115. Schrier RW, Arroyo V, Bernardi M et al. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988; 8:1151-7.
116. Colombato LA, Albillos A, Groszmann RJ. Temporal relationship of peripheral vasodilatation, plasma volume expansion and the hyperdynamic circulatory state in portal-hypertensive rats. Hepatology 1991; 15:323-8.
117. Albillos A, Colombato LA, Groszmann RJ. Vasodilatation and sodium retention in prehepatic portal hypertension. Gastroenterology 1992; 102:931-5.
118. Korthius RJ, Kinden DA, Brimer GE et al. Intestinal capillary filtration in acute and chronic portal hypertension. Am J Physiol 1988; 254:G339-G345.